Zoetis Inc.
ZTS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001555280
No open-market purchases or sales by Zoetis Inc. insiders were filed in the last 90 days; 1,433 institutions reported holding it in 13F filings for Q2 2026, worth $28.6B in total; superinvestors Markel Group and Soros Fund Management hold it.
13F holders, Q2 2023
Institutional positions in Zoetis Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,630
- +82 vs. Q1 2023
- Shares held
- 418.2M
- −43.0M (−9.3%) vs. Q1 2023
- Total value
- $72.0B
- +$1.50B (+2.1%) vs. Q1 2023
- New holders
- 156
- 657 more added
- Sold out
- 74
- 577 more reduced
13 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1,433 | $28.6B |
| Q1 2026 | 1,618 | $48.2B |
| Q4 2025 | 1,685 | $51.8B |
| Q3 2025 | 1,805 | $60.1B |
| Q2 2025 | 1,873 | $66.1B |
| Q1 2025 | 1,890 | $68.9B |
| Q4 2024 | 1,876 | $68.3B |
| Q3 2024 | 1,790 | $81.7B |
| Q2 2024 | 1,742 | $73.5B |
| Q1 2024 | 1,742 | $72.2B |
| Q4 2023 | 1,749 | $84.4B |
| Q3 2023 | 1,631 | $73.4B |
| Q2 2023 | 1,630 | $72.0B |
| Q1 2023 | 1,561 | $70.5B |
| Q4 2022 | 1,523 | $62.1B |
| Q3 2022 | 1,512 | $63.3B |
| Q2 2022 | 1,567 | $73.6B |
| Q1 2022 | 1,641 | $81.2B |
| Q4 2021 | 1,675 | $104.3B |
| Q3 2021 | 1,484 | $83.5B |
| Q2 2021 | 1,452 | $80.1B |
| Q1 2021 | 1,417 | $68.2B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Zoetis Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| WestEnd Advisors, LLC | 0 | $0 | 0.00% | – | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Sugarloaf Wealth Management, LLC | 0 | $0 | 0.00% | 0 | Sold out |
| Summit Wealth Group, LLC | 0 | $0 | 0.00% | −14,980−100.0% | Sold out |
| Fithian, LLC | – | – | – | – | Not filed |
| ETF Managers Group, LLC | – | – | – | – | Not filed |
| Security Asset Management | – | – | – | – | Not filed |
| HighTower Trust Services, LTA | – | – | – | – | Not filed |
| Altman Advisors, Inc. | – | – | – | – | Not filed |
| Investment Management of Virginia LLC | – | – | – | – | Not filed |
| SS&H Financial Advisors, Inc. | – | – | – | – | Not filed |
| Avalon Investment & Advisory | – | – | – | – | Not filed |
| Catalyst Wealth Management, LLC | – | – | – | – | Not filed |
| LeJeune Puetz Investment Counsel LLC | – | – | – | – | Not filed |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |
| Baldrige Asset Management LLC | – | – | – | – | Not filed |
| Ahrens Investment Partners LLC | – | – | – | – | Not filed |